Reply to thread

Message: <blockquote data-quote="imhotep" data-source="post: 26411946" data-attributes="member: 562115">Results of a study of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the UK variant of concern B.1.1.7), admissions to hospital, and deaths.Results from 156 930 adults aged 70 years and older who reported symptoms of covid-19 between 8 December 2020 and 19 February 2021.[ATTACH=full]125033[/ATTACH]This study shows that <ul> <li data-xf-list-type="ul">A single dose of either BNT162b2 or ChAdOx1-S provides significant protection against covid-19 and further protection against severe disease lasting at least six weeks, including against the UK variant of concern (B.1.1.7)</li> <li data-xf-list-type="ul">BNT162b2 and ChAdOx1-S offer similar levels of protection in adults aged 70 and older</li> </ul>(From the BMJ)</blockquote>

Top Bottom